Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $771.32 ($78K) on 2026-04-01, disclosed to the SEC on 2026-04-03.
Scheduled sale ($78k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $771.32 | 1 | $771 | 1.0% |
| 2 | $772.76 | 3 | $2K | 3.0% |
| 3 | $773.59 | 8 | $6K | 8.0% |
| 4 | $774.58 | 8 | $6K | 8.0% |
| 5 | $775.58 | 14 | $11K | 14.0% |
| 6 | $776.62 | 13 |
| $10K |
| 13.0% |
| 7 | $777.42 | 9 | $7K | 9.0% |
| 8 | $778.24 | 4 | $3K | 4.0% |
| 9 | $779.71 | 40 | $31K | 40.1% |
| Total | $777.27 avg | 100 | $78K | 100% |
| Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |
| REGN | SELL | 2024-10-03 | $105K | — | Filing → |